Delivery Order SPE2DB22D2206-SPE2DB24FFX84
Award Date 3/5/24
Potential Completion Date 3/26/24
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,756.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563892824 - HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HYPERRAB 300 UNIT/ML VIALML pharmaceutical products. The $3,721.90 Firm Fixed Price contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,004.32 firm fixed price delivery order provides for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,391.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to Conshohocken, Pennsylvania by March 12, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,466.28 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide pharmaceutical products, including HYPERRAB 300 UNIT/ML VIALML. This delivery order has a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) also awarded by DLA, with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,174.40 firm fixed price delivery order contract to supply HYPERRAB 300 UNIT/ML VIALML pharmaceutical products. This order is not associated with a set-aside program and is scheduled for completion by January 18, 2024. Amerisourcebergen has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical operations. The...
- This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $5,622.80 and runs through June 12, 2024. It was issued as a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award is a delivery order with a firm fixed price of $1,732.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), a Defense agency, to provide HYPERRAB 300 UNIT/ML VIALML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $9,391.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with a period of performance through October 29, 2024. The contract has a Firm Fixed Price pricing type and does not have a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...